Company: BIVIW
Filing Date: 2025-09-25
Form Type: DEF 14A
Source: 0001520138-25-000287
Chunk: 24

Company: BIOVIE INC.
Filing Date: 2025-09-25
Form: DEF 14A
Chunk 24
---
 |     | $      | 34,602 |     | $      |  34,650 |     | $              | — |     | $            | — |     | $            | — |     | $     | 339,252 |
| Joseph Palumbo                                  |     |      |     |        |         |     |       |         |     |        |        |     |        |         |     |                |   |     |              |   |     |              |   |     |       |         |
| Chief Medical Officer                           |     | 2025 |     | $      | 560,000 |     | $     |  84,000 |     | $      |      — |     | $      |  22,051 |     | $              | — |     | $            | — |     | $            | — |     | $     | 666,051 |
|                                                 |     | 2024 |     | $      | 560,000 |     | $     |       — |     | $      | 54,984 |     | $      |  54,600 |     | $              | — |     | $            | — |     | $            | — |     | $     | 669,584 |

| (1) | The aggregate grant date fair value                                                                                                       
 of such awards were computed in accordance with Financial Accounting Standards Board ASC Topic 718, Stock Compensation (ASC Topic 718),   
 and do not take into account estimated forfeitures related to service-based vesting conditions, if any. The valuation assumptions used    
 in calculating these values are discussed in Note 10 of our Notes to Financial Statements included in our Annual Report on Form 10-K      
 for the year ended June 30, 2025. These amounts do not represent actual amounts paid or to be realized. Amounts shown are not necessarily 
 indicative of values to be achieved, which may be more or less than the amounts shown as awards may subject to time-based vesting. The    
 stock awards in form of restricted stock units (“RSUs”) and stock option awards were awarded pursuant to the 2019 Plan.                   |

| -15- |

Narrative Disclosures to Summary Compensation Table

Employment Agreements

All employment arrangements are “at will” agreements.

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth all outstanding equity awards held by our
NEOs as of June